Primary Prevention of Coronary Heart Disease in Women: Should Asymptomatic Women 50 Years of Age Take Aspirin Regularly?

doi:10.1001/archfami.1994.01850170077023

Institution: CLOCKSS | My Account | E-mail Alerts | Access Rights | Sign In

Vol. 3 No. 4, April 1994

Archives

• Online Features

Clinical Review

This Article

• Abstract

• Full text PDF

• Send to a friend

• Save in My Folder

• Save to citation manager

• Permissions

Citing Articles

• Citation map

• Citing articles on HighWire

• Contact me when this article is cited

Related Content

• Similar articles in this journal

Primary Prevention of Coronary Heart Disease in Women
Should Asymptomatic Women 50 Years of Age Take Aspirin Regularly?
Scott E. Woods, MD

Arch Fam Med. 1994;3(4):361-364.

References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Eaker E, Packard B, Thom T. Epidemiology and risk factors for coronary heart disease in women. In: Douglas P, ed. Heart Disease in Women. New York, NY: Davis Co; 1989:129-145. Cardiobascular Clinics Series No. 3.
2. Eaker E, Packard B, Wenger N, Clarkson T, Tyroler H, eds. Coronary Heart Disease in Women: Proceedings of an NIH Workshop. New York, NY: Haymarket Doyma Inc; 1987:190-194.
3. Wenger N. Coronary disease in women. Annu Rev Med. 1985;36:285-294. PUBMED
4. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129-135. PUBMED
5. Smith J, Willis A. Aspirin selectively inhibits prostaglandin production in human platelets. Nature. 1971;231:235-237.
6. Roth G, Majerus P. The mechanism of the effect of aspirin on human platelets. J Clin Invest. 1975;56:624-632. PUBMED
7. Cairs J, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med. 1985;313:1369-1375. PUBMED
8. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105-1111. PUBMED
9. Aspirin after myocardial infarction. Lancet. 1980;1:1172-1173. Editorial. PUBMED
10. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ. 1988;296:320-331. FREE FULL TEXT
11. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360. PUBMED
12. Peto R, Gray R, Collins R, et al. Randomized trial of prophylactic daily aspirin in British male doctors. BMJ. 1988;296:313-316. FREE FULL TEXT
13. US Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force. Baltimore, Md: Williams & Wilkins; 1989.
14. Hammond E, Garfinkel L. Aspirin and coronary heart disease. BMJ. 1975;2:269-271. FREE FULL TEXT
15. Paganini-Hill A, Chao A, Ross R, Henderson B. Aspirin use and chronic diseases. BMJ. 1989;299:1247-1250. FREE FULL TEXT
16. Manson J, Stampfer M, Colditz G, et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA. 1991;226:521-527.
17. Everhart J, Knowler W, Bennett P. Incidence and risk factors for non-insulin-dependent diabetes. In: Diabetes in America. Rockville, Md: National Institutes of Health; 1985:iv-1. National Institutes of Health publication 85-1468.
18. Stampfer M, Colditz G, Willett W, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756-762. PUBMED
19. Wolf P, Kannel W, McGee D. Epidemiology of strokes in North America. In: Mohr J, Barnett H, Stein B, Yatsu F, eds. Stroke. New York, NY: Churchill Livingstone Inc; 1986:23.
20. Hirsh J, Dalen J, Fuster V, et al. Aspirin and other platelet-active drugs. Chest. 1993;102(suppl_2):327S-336S.